CRT 2024

CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: DurAVR Biomimetic Transcatheter Heart Valve: Early Feasibility Study (EFS) Update

Interviewer(s)

• 

  Toby Rogers, MD, PhD

  Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
  Georgetown University and MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure information not submitted.

Interviewee(s)

• 

  Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI

  Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
  US Heart & Vascular, Tucson Medical Center

  No relationships to disclose